irritable bowel syndrome
A positive diagnosis (Rome IV), not a diagnosis of exclusion: recurrent abdominal pain ≥1 day/week for 3 months linked to defecation or a change in stool frequency or form. Test minimally: coeliac serology; no routine colonoscopy under 50 without alarm features; new symptoms at ≥50 → colonoscopy. Treat by subtype after explanation and reassurance: low-FODMAP diet, psyllium, peppermint oil, antispasmodics, low-dose TCA (strongest evidence for pain), linaclotide for IBS-C. CAG 2019 is the Canadian reference; ACG and AGA differ on several drugs.
diagnosis
Rome IV: recurrent abdominal pain on average ≥1 day/week in the last 3 months, with ≥2 of: related to defecation · change in stool frequency · change in stool form. Onset ≥6 months before diagnosis.
Subtype by stool form on bad days (Bristol): IBS-C, IBS-D, IBS-M.
what to test (CAG 2019)
| test | recommendation |
|---|---|
| coeliac serology | yes (CAG: all IBS; ACG: IBS with diarrhoea) |
| CRP, calprotectin | CAG against routinely; ACG suggests both in IBS-D without alarm features to exclude IBD |
| colonoscopy, <50 without alarm features | no (CAG; ACG: <45) |
| colonoscopy, <50 with alarm features | not routinely — individualise |
| new symptoms at ≥50 | colonoscopy |
| food allergy tests, lactose or glucose breath tests | no |
Alarm features : age ≥50 at onset, rectal bleeding, nocturnal symptoms, weight loss, iron deficiency anaemia, family history of CRC, IBD or coeliac, palpable mass → investigate (chronic diarrhoea).
treatment
Explain the diagnosis (gut–brain interaction, visceral hypersensitivity) and that it doesn’t progress to serious disease. Then target the dominant symptom.
all subtypes
| therapy | CAG 2019 | note |
|---|---|---|
| low-FODMAP diet | suggest | restrict 2–6 weeks → reintroduce → personalise; dietitian-led |
| psyllium (soluble fibre) | recommend | avoid wheat bran (insoluble — worsens bloating) |
| gluten-free diet | against | |
| peppermint oil | suggest | |
| antispasmodics (dicyclomine, hyoscine, pinaverium) | suggest | ACG recommends against |
| probiotics | suggest | ACG suggests against |
| low-dose TCA (amitriptyline from 10 mg qhs, titrate) | recommend | best evidence for pain; constipating → good for IBS-D |
| SSRI | suggest | |
| CBT, gut-directed hypnotherapy | suggest |
IBS-D
- Eluxadoline: suggested.
- Rifaximin: CAG no recommendation; ACG recommends.
- Continuous loperamide: CAG against (helps stool frequency, not pain or global symptoms) — fine as needed.
- Bile acid sequestrant: CAG against for IBS; test/treat bile acid diarrhoea separately (chronic diarrhoea).
IBS-C
- Linaclotide: recommend (CAG); lubiprostone: suggest.
- Osmotic laxatives (PEG): CAG and ACG suggest against for global IBS symptoms — they improve constipation, not pain or bloating; still reasonable for stool frequency.
- Prucalopride: against for overall IBS-C symptoms.
- Constipation with straining or incomplete evacuation → consider dyssynergic defecation (anorectal physiology testing).
Prepared 2026-10-28. Not yet verified — check every number against the sources.